KLF4 and acute myeloid leukemia: AML-PDX cells were treated with DMSO, ABZ (100 nM), or PBZ (100 nM) for 48 h, and the expressions of monocyte markers, morphology, apoptosis, and KLF4/DPYSL2A mRNA expression were examined in vitro.